• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Beyond Undetectable Viral Load: Effect of Nucleotides on Inflammation.

作者信息

Moreno Santiago, Serrano-Villar Sergio

机构信息

Department of Infectious Diseases, Hospital Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.

Department of Infectious Diseases, Hospital Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.

出版信息

EBioMedicine. 2016 Nov;13:31-32. doi: 10.1016/j.ebiom.2016.10.015. Epub 2016 Oct 13.

DOI:10.1016/j.ebiom.2016.10.015
PMID:27765640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5264241/
Abstract
摘要

相似文献

1
Beyond Undetectable Viral Load: Effect of Nucleotides on Inflammation.超越病毒载量不可检测：核苷酸对炎症的影响。
EBioMedicine. 2016 Nov;13:31-32. doi: 10.1016/j.ebiom.2016.10.015. Epub 2016 Oct 13.
2
Residual HIV-1 disease in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代的残余HIV-1疾病
N Engl J Med. 1999 May 27;340(21):1672-4. doi: 10.1056/NEJM199905273402110.
3
[Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].[人类免疫缺陷病毒1型感染过程中的病毒动力学：发病机制特点及新的治疗前景]
Pathologica. 2000 Aug;92(4):291-3.
4
Vaccination and HIV-1 replication during highly active antiretroviral therapy.高效抗逆转录病毒治疗期间的疫苗接种与HIV-1复制
AIDS. 1999 Jan 14;13(1):135-6.
5
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.抗逆转录病毒治疗实现 10 年病毒持续控制的免疫和病毒学获益。
AIDS. 2010 Feb 20;24(4):614-7. doi: 10.1097/QAD.0b013e32833556f3.
6
Antiretroviral resistance.抗逆转录病毒耐药性
J HIV Ther. 2006 Dec;11(4):72-3.
7
Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.接受高效抗逆转录病毒治疗（HAART）失败的HIV-1感染患者中CD4阳性T细胞计数的不一致变化
Jpn J Infect Dis. 2002 Apr;55(2):62-5.
8
Reservoirs for HIV infection and their persistence in the face of undetectable viral load.
AIDS Patient Care STDS. 2001 Oct;15(10):511-8. doi: 10.1089/108729101753205676.
9
HAART version 2.0.
GMHC Treat Issues. 2002 Mar;16(3):1-4.
10
Exploring the benefits and limits of highly active antiretroviral therapy.探索高效抗逆转录病毒疗法的益处与局限。
JAMA. 1999 Nov 3;282(17):1668-9. doi: 10.1001/jama.282.17.1668.

引用本文的文献

1
Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?用于治疗HIV感染的联合抗逆转录病毒疗法方案是否具有多样的T细胞表型和炎症特征？
Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa340. doi: 10.1093/ofid/ofaa340. eCollection 2020 Sep.

本文引用的文献

1
Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide.替诺福韦酯与替诺福韦艾拉酚胺在炎症标志物方面的等效下降情况
EBioMedicine. 2016 Nov;13:321-327. doi: 10.1016/j.ebiom.2016.10.009. Epub 2016 Oct 11.
2
Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients.雷特格韦与依非韦伦对HIV感染患者CD4/CD8比值恢复的不同影响。
J Antimicrob Chemother. 2017 Jan;72(1):235-239. doi: 10.1093/jac/dkw375. Epub 2016 Sep 21.
3
Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.接受治疗的HIV感染中的免疫生物标志物、发病率和死亡率。
J Infect Dis. 2016 Oct 1;214 Suppl 2(Suppl 2):S44-50. doi: 10.1093/infdis/jiw275.
4
Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care.缩小接受治疗的HIV感染者与未感染HIV个体之间的预期寿命差距。
J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):39-46. doi: 10.1097/QAI.0000000000001014.
5
Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study.丹麦有和无 HIV 感染个体发生严重与年龄相关疾病风险的时间趋势：一项全国基于人群的队列研究。
Lancet HIV. 2015 Jul;2(7):e288-98. doi: 10.1016/S2352-3018(15)00077-6. Epub 2015 May 27.
6
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.早期无症状HIV感染中抗逆转录病毒治疗的启动
N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.
7
Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.在HIV感染个体中，基于整合酶抑制剂的初始抗逆转录病毒疗法对单核细胞激活和血管炎症的差异降低作用
J Infect Dis. 2015 Aug 1;212(3):345-54. doi: 10.1093/infdis/jiv004. Epub 2015 Jan 12.
8
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.预测 HIV 感染期间的癌症风险：炎症和凝血生物标志物的作用。
AIDS. 2013 Jun 1;27(9):1433-41. doi: 10.1097/QAD.0b013e32835f6b0c.
9
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.HIV 与衰老：知识现状和研究关键需求领域。HIV 和衰老工作组向美国国立卫生研究院艾滋病研究办公室提交的报告。
J Acquir Immune Defic Syndr. 2012 Jul 1;60 Suppl 1(Suppl 1):S1-18. doi: 10.1097/QAI.0b013e31825a3668.
10
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.HIV感染患者的炎症和凝血生物标志物与死亡率
PLoS Med. 2008 Oct 21;5(10):e203. doi: 10.1371/journal.pmed.0050203.